| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |